Adaeze O. is 58, a school administrator in Lagos, and had been carrying a triple-vessel disease
diagnosis for four months when she first messaged us. She had three quotes from three India
hospitals, forwarded to her by three different agents, ranging from
$5,900 to $14,200.
None of them explained why.
"I assumed the cheap one was a scam and the expensive one was the good hospital," she told us
afterwards. "That is what you assume when you have nothing else to go on."
The difference, when we laid the three side by side, was almost entirely in what had been left
out. The cheapest quote assumed two ICU days; her diabetes and kidney function made four
realistic. It also excluded the pre-operative workup entirely. The most expensive quote was for
a private suite she neither needed nor wanted, at a hospital with a lower annual bypass volume
than the middle option.
What actually happened
Two consultants reviewed her angiography. Both recommended a triple bypass; they differed on
whether to use one arterial graft or two, which we put to her in plain language along with what
the trade-off meant at 58. She chose the two-graft plan and the surgeon with 4,800 cases behind
him.
She flew on a Tuesday, was operated on the following Monday, and was discharged nine days later.
The final bill came to $8,100 against a quote of
$7,900 — the difference being one extra ICU night, at the
per-day rate printed on her quote.
"I had three quotes and no way to compare them. MEDYRA put them in one table, told me which
implant each one meant, and which surgeon had done the most of my particular operation.
That was the whole value."
She is back at work. Her ninety-day review was in February, by video, with the surgeon who
operated on her and an interpreter she did not, in the end, need.